Gamaleya Research Institute of Epidemiology and Microbiology

55°48′06″N 37°27′27″E / 55.8017°N 37.4576°E / 55.8017; 37.4576

Gamaleya Research Institute of Epidemiology and Microbiology
Formation1891 (1891) (as N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology)
FounderFilipp Blymenthal
PurposeFund vaccine development
Headquarters18 Gamaleya Street
Moscow, Russia 123098
Director General
Alexander Gintsburg
Parent organization
Ministry of Health of the Russian Federation
Staff379 (including 92 professors)
Websitegamaleya.org (in Russian)
gamaleya.org/en(in English)

The Gamaleya Research Institute of Epidemiology and Microbiology, previously the N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology, is a Russian medical-research institute within the Ministry of Health of the Russian Federation.

Founded in 1891 by Filipp Markovich Blyumental, it is named after Soviet scientist Nikolay Fyodorovich Gamaleya (1859–1949), famed as a pioneer in microbiology and in vaccine research. The institute is best known internationally for developing the earliest vaccine for SARS-CoV-2, in collaboration with the 48th Central Research Institute of the Ministry of Defence and the Vector Institute of the Rospotrebnadzor, in response to the COVID-19 pandemic.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.